| 股票 | 富途行业 | PE | PB | 股息率 | 分红率 | 毛利率 | ROE | 固定资产 | 负债率 | OCF/市值 | 营收增速 | 利润增速 | 近60日 | YTD | 近一年 | 距52周高 | 市值亿 ▴ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Collegium Pharmaceutical COLL | 专业与通用药品制造商 | 18.5 | 2.34 | 0.0% | 0% | 59% | 24% | 1% | 82% | 45.2% | +24% | -9% | -32% | -49% | -38% | 46% | 7 |
| Hims & Hers Health HIMS | 专业与通用药品制造商 | -43.3 | 19.95 | 0.0% | — | 74% | 25% | 11% | 75% | 4.1% | +59% | +2% | -0% | -15% | -44% | 42% | 65 |
| Lantheus LNTH | 专业与通用药品制造商 | 24.2 | 5.02 | 0.0% | 0% | 61% | 21% | 7% | 51% | 6.3% | +0% | -25% | +1% | +52% | +88% | 90% | 66 |
| 神经分泌生物科学 NBIX | 专业与通用药品制造商 | 22.8 | 4.28 | 0.0% | 0% | 98% | 16% | 8% | 30% | 5.7% | +21% | +40% | -3% | +10% | +8% | 84% | 158 |
| 美国联合医疗 UTHR | 专业与通用药品制造商 | 17.5 | 3.27 | 0.0% | 0% | 88% | 20% | 13% | 10% | 8.1% | +11% | +12% | -10% | +0% | +24% | 80% | 209 |
| Zoetis ZTS | 专业与通用药品制造商 | 12.4 | 9.95 | 2.7% | 34% | 72% | 66% | 22% | 78% | 9.1% | +2% | +7% | -6% | -39% | -49% | 50% | 313 |
| 梯瓦制药 TEVA | 专业与通用药品制造商 | 60.6 | 5.46 | 0.0% | 0% | 52% | 21% | 12% | 81% | 4.5% | +4% | +172% | +8% | +16% | +88% | 95% | 424 |
点表头排序。市值单位亿美元;财务为最近年报(futu 筛选器);分红率 = 股息率 × PE;OCF/市值 = 经营现金流 ÷ 市值(无 FCF);距52周高 = 现价 / 52 周最高。